APA
Bryce A. H., Borad M. J., Egan J. B., Condjella R. M., Liang W. S., Fonseca R., McCullough A. E., Hunt K. S., Ritacca N. R., Barrett M. T., Patel M. D., Young S. W., Silva A. C., Ho T. H., Halfdanarson T. R., Stanton M. L., Cheville J., Swanson S., Schneider D. E., McWilliams R. R., Baker A., Aldrich J., Kurdoglu A., Izatt T., Christoforides A., Cherni I., Nasser S., Reiman R., Cuyugan L., McDonald J., Adkins J., Mastrian S. D., Von Hoff D. D., Craig D. W., Stewart A. K. & Carpten J. D. (20180925). Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib. : Clinical genitourinary cancer.
Chicago
Bryce Alan H, Borad Mitesh J, Egan Jan B, Condjella Rachel M, Liang Winnie S, Fonseca Rafael, McCullough Ann E, Hunt Katherine S, Ritacca Nicole R, Barrett Michael T, Patel Maitray D, Young Scott W, Silva Alvin C, Ho Thai H, Halfdanarson Thorvardur R, Stanton Melissa L, Cheville John, Swanson Scott, Schneider Daniel E, McWilliams Robert R, Baker Angela, Aldrich Jessica, Kurdoglu Ahmet, Izatt Tyler, Christoforides Alexis, Cherni Irene, Nasser Sara, Reiman Rebecca, Cuyugan Lori, McDonald Jacquelyn, Adkins Jonathan, Mastrian Stephen D, Von Hoff Daniel D, Craig David W, Stewart A Keith and Carpten John D. 20180925. Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib. : Clinical genitourinary cancer.
Harvard
Bryce A. H., Borad M. J., Egan J. B., Condjella R. M., Liang W. S., Fonseca R., McCullough A. E., Hunt K. S., Ritacca N. R., Barrett M. T., Patel M. D., Young S. W., Silva A. C., Ho T. H., Halfdanarson T. R., Stanton M. L., Cheville J., Swanson S., Schneider D. E., McWilliams R. R., Baker A., Aldrich J., Kurdoglu A., Izatt T., Christoforides A., Cherni I., Nasser S., Reiman R., Cuyugan L., McDonald J., Adkins J., Mastrian S. D., Von Hoff D. D., Craig D. W., Stewart A. K. and Carpten J. D. (20180925). Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib. : Clinical genitourinary cancer.
MLA
Bryce Alan H, Borad Mitesh J, Egan Jan B, Condjella Rachel M, Liang Winnie S, Fonseca Rafael, McCullough Ann E, Hunt Katherine S, Ritacca Nicole R, Barrett Michael T, Patel Maitray D, Young Scott W, Silva Alvin C, Ho Thai H, Halfdanarson Thorvardur R, Stanton Melissa L, Cheville John, Swanson Scott, Schneider Daniel E, McWilliams Robert R, Baker Angela, Aldrich Jessica, Kurdoglu Ahmet, Izatt Tyler, Christoforides Alexis, Cherni Irene, Nasser Sara, Reiman Rebecca, Cuyugan Lori, McDonald Jacquelyn, Adkins Jonathan, Mastrian Stephen D, Von Hoff Daniel D, Craig David W, Stewart A Keith and Carpten John D. Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib. : Clinical genitourinary cancer. 20180925.